http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190076711-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7ddc4774cf5f8a0bda44a780d73c53d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| filingDate | 2017-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6dc61b9eb0b6d252f865e61154c1855f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17a13e8d138e16c7d0b3da6595f7e375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49359d5758e4125e46dd1d4a113d74e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_affc42884de5f3233aa31b8d19e37022 |
| publicationDate | 2019-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20190076711-A |
| titleOfInvention | A hard capsule formulation comprising memantine with immediate and sustained release properties and a process for the preparation thereof |
| abstract | One aspect is a medicament in the form of a tablet comprising memantine or a pharmaceutically acceptable salt thereof; And a sustained release form of tablets comprising memantine or a pharmaceutically acceptable salt thereof, wherein the dissolution rate of memantine or a pharmaceutically acceptable salt thereof is 30 to 50% per hour, and at 2 hours 40 to 60%, and a preparation method thereof. The hard capsule preparation according to one aspect of the present invention simultaneously contains both the immediate and extended portions including memantine, so that the initial bioavailability is excellent and the sustained release characteristics can be improved to improve the patient's compliance with the medication. Thus, the early and severe prevention or treatment of Alzheimer's disease Can be usefully used. |
| priorityDate | 2017-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.